NutriSelect Expands Intellectual Property Portfolio with Second U.S. Provisional Patent Filing

NutriSelect.ai today announced the successful filing of its second U.S. provisional patent application, marking another major milestone in the development of the company’s Precision Supplement Intelligence™ platform.

The new filing significantly expands NutriSelect’s intellectual property beyond its original NScore™ scientific rating methodology to encompass a broader AI-powered system for evidence-based evaluation, classification, personalization, and adaptive optimization of dietary supplements and nutritional ingredients. The application has been officially received by the United States Patent and Trademark Office (USPTO).

This expanded intellectual property reflects more than a year of continued platform innovation, including:

• AI-driven personalization based on individual health goals and preferences
• Scientific credibility scoring at both the product and ingredient levels
• Explainable AI recommendation engine with transparent scientific rationale
• Adaptive recommendation capabilities that evolve with user profiles
• Structured evaluation frameworks integrating clinical evidence, formulation quality, transparency, regulatory compliance, and scientific integrity
• Future-ready architecture supporting continuous learning as new evidence emerges

Unlike traditional supplement recommendation platforms that primarily emphasize marketing claims or popularity, NutriSelect evaluates products through a structured scientific framework designed to help consumers make evidence-informed decisions.

“This filing represents an important evolution of our long-term vision,” said Dr. Bill Clark, PhD, Founder and CEO of NutriSelect.ai. “We’re building much more than a supplement recommendation app. We’re creating the credibility infrastructure for evidence-based supplementation—an intelligence platform that brings transparency, scientific rigor, and trust to an industry that has long lacked standardized evaluation.”

The expanded patent portfolio complements NutriSelect’s growing ecosystem, including the NScore™ scientific credibility framework, Precision Supplement Intelligence™, the Ingredient Science Accelerator™, Product Science Accelerator™, and the company’s AI-powered evidence evaluation platform.

As NutriSelect prepares for its planned soft launch later this year, the strengthened intellectual property portfolio reinforces the company’s commitment to building defensible technology that benefits consumers, healthcare professionals, ingredient innovators, and responsible supplement brands.

“This milestone strengthens the foundation for what comes next,” added Dr. Clark. “Our mission remains unchanged: empowering better health decisions through credible science and transparent AI.”